Eight of 16 patients participating in a study of an experimental immune system therapy directed against the most aggressive malignant brain tumors – glioblastoma multiforme – survived longer than five years after diagnosis, according to new research.
Fuente : http://feeds.sciencedaily.com/~r/sciencedaily/~3/q...
Fuente : http://feeds.sciencedaily.com/~r/sciencedaily/~3/q...